Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance
Wolff, M., Evens, R., Mertens, L. J., Koslowski, M., Betzler, F., Gründer, G., & Jungaberle, H. | Frontiers in Psychiatry | 21 February 2020
Microdosing psychedelics: Motivations, subjective effects and harm reduction.
Lea, T., Amada, N., Jungaberle, H., Schecke, H., & Klein, M. | International Journal of Drug Policy | 25 November 2019
Positive psychology in the investigation of psychedelics and entactogens: A critical review
Jungaberle, H., Thal, S., Zeuch, A., Rougemont-Bücking, A., von Heyden, M., Aicher, H., & Scheidegger, M. | Neuropharmacology | 29 June 2018
Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review
Reiche, S., Hermle, L., Gutwinski, S., Jungaberle, H., Gasser, P., & Majić, T. | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 22 September 2017
Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges
Majić, T., Jungaberle, H., Schmidt, T. T., Zeuch, A., Hermle, L., & Gallinat, J. | Fortschritte der Neurologie-Psychiatrie | 2 August 2017